Asaturova Aleksandra, Dobrovolskaya Darya, Magnaeva Alina, Tregubova Anna, Bayramova Guldana, Sukhikh Gennady
FSBI "National Medical Research Centre for Obstetrics, Gynecology and Perinatology Named after Academician V.I.Kulakov" of the Ministry of Health of the Russian Federation, 4, Oparina Street, 117513 Moscow, Russia.
Diagnostics (Basel). 2022 Jan 15;12(1):210. doi: 10.3390/diagnostics12010210.
Recent evidence suggests that a cytology-histology correlation (CHC) with discrepancy detection can both evaluate errors and improve the sensitivity and specificity of the cytologic method. We aimed to analyze the errors in cytologic-histologic discrepancies according to the CHC protocol guideline of the American Society of Cytopathology (2017). This retrospective study included 273 patients seen at the National Medical Research Center of Obstetrics, Gynecology and Perinatology (Moscow, Russia) between January 2019 and September 2021. The patients' mean age was 34 ± 8.1 years. The cytology-histology agreement was noted in 158 cases (57.9%). Major discrepancies were found in 21 cases (7.6%), while minor discrepancies were noted in 93 cases (34.1%). The reason for 13 (4.8%) discrepancies was a colposcopy sampling error and, in 46 (16.8%) cases, the reason was a Papanicolaou (PAP) test sampling error. The discrepancy between primary and reviewed cytology was due interpretive errors in 13 (4.8%) cases and screening errors in 42 (15.4%) cases. We demonstrated that the ASC guidelines facilitate cervical CHC. A uniform application of these guidelines would standardize cervical CHCs internationally, provide a scope for the inter-laboratory comparison of data, and enhance self-learning and peer learning.
最近的证据表明,具有差异检测功能的细胞学-组织学相关性(CHC)既能评估错误,又能提高细胞学方法的敏感性和特异性。我们旨在根据美国细胞病理学学会(2017年)的CHC方案指南,分析细胞学-组织学差异中的错误。这项回顾性研究纳入了2019年1月至2021年9月期间在俄罗斯莫斯科国家妇产科和围产医学研究中心就诊的273例患者。患者的平均年龄为34±8.1岁。158例(57.9%)病例存在细胞学-组织学一致性。21例(7.6%)发现主要差异,93例(34.1%)发现次要差异。13例(4.8%)差异的原因是阴道镜检查取样错误,46例(16.8%)病例的原因是巴氏(PAP)试验取样错误。初次细胞学检查与复查细胞学检查之间的差异,13例(4.8%)是由于解释错误,42例(15.4%)是由于筛查错误。我们证明了美国细胞病理学学会的指南有助于宫颈CHC。统一应用这些指南将在国际上规范宫颈CHC,为实验室间的数据比较提供空间,并加强自我学习和同行学习。